A Randomised, Double-blind, Active-controlled, 3 Way Cross-over Study to Evaluate the Effect on Trough FEV1 After 4 Weeks Treatment With CHF 5188 pMDI qd (Fixed Combination Budesonide / Carmoterol) in Adult Patients With Moderate or Severe Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Budesonide/carmoterol (Primary) ; Budesonide; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 04 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2010 New trial record